Distant Electromagnetic Pulses Accelerate Bone Fracture Healing by One Week in Rats

Bone fractures, particularly of long tubular bones, represent a major global health burden, contributing to disability and prolonged recovery. Conventional treatments — from skeletal traction to surgical fixation with plates and screws — carry risks including anesthetic complications, periosteal damage, and osteomyelitis. This preclinical study from Russia's Scientific Research Institute of General Pathology and Pathophysiology investigated whether a commercially registered, non-contact pulsed electromagnetic field (PEMF) device could accelerate fracture healing without any direct physical contact with the subject.

Forty-eight white nonlinear male rats (230–250 g) were divided equally into control and experimental groups and housed in separate rooms to prevent inadvertent EMF exposure of controls. All animals underwent identical surgery: a 1 cm incision over the right hindlimb tibia, creation of a non-displaced fracture at the proximal epiphysis, and wound closure with non-absorbable suture. The experimental group received treatment from the TOR device — a registered Russian medical device generating weak, non-ionizing, non-thermal electromagnetic radiation via high-voltage pulses (5–8 kV amplitude, 100–150 Hz frequency, 25 kHz harmonic modes) at up to 80 watts — three times daily (20:00, 02:00, 08:00) for 5 minutes per session over 14 days. Six animals per group were sacrificed weekly for blood analysis and X-ray examination of excised limbs.

The most striking radiographic finding was the timeline of bone consolidation. By day 16, all experimental animals showed clear consolidation and dense bone callus formation, while only 33.3% of controls showed active consolidation without callus. By day 21–23, all experimental animals demonstrated near-complete primary healing with full consolidation and no fibrosis signs. In the control group, only one animal showed comparable healing at that timepoint. Complete bone fusion occurred at day 23 in the experimental group versus day 30 in controls — a 23% reduction in healing time.

Infection outcomes were equally notable. By day 16, 83% of control animals had developed subcutaneous purulent abscesses at the surgical site, while zero abscesses were observed in the PEMF-treated group. By day 30, cyanotic muscle discoloration was present in 67% of controls versus only 17% of PEMF animals. Scar formation at day 6 was also lower in the experimental group (17% vs. 67% of animals). These findings collectively suggest a meaningful anti-inflammatory and antimicrobial effect of the PEMF exposure.

Blood morpho-biochemical analysis supported the clinical observations. The experimental group showed decreased total leukocyte counts (consistent with reduced systemic inflammation), increased erythrocyte and platelet counts across all measurement timepoints, and a statistically significant rise in serum calcium ions during the final week of the trial — a finding consistent with accelerated bone mineralization. Body weight trajectories also differed: PEMF animals gained weight more slowly than controls post-surgery, which the authors interpret as reflecting the higher metabolic energy demand of accelerated bone tissue regeneration rather than a negative effect.

While the results are promising, several important caveats apply. The study is small (n=48 total, n=6 per group per timepoint), conducted in a single rodent model, and the mechanism by which a remotely applied, low-power electromagnetic field influences bone healing at a cellular level remains unexplained. The device's claimed range of up to 700 meters and its prior use in COVID-19 treatment add an unusual context that warrants independent replication. Nonetheless, the consistency of findings across radiographic, hematological, and clinical outcome measures makes this a noteworthy preclinical signal for non-contact PEMF therapy in orthopedic recovery.